Core Viewpoint - The company, Aidi Te (301580), confirmed that its production and operations are normal as of November 7, responding to investor inquiries on an interactive platform [1] Group 1 - The company is actively engaging with investors through an interactive platform [1] - The confirmation of normal production and operations indicates stability within the company [1]

证券代码：301580 证券简称：爱迪特 公告编号：2025-055 爱迪特（秦皇岛）科技股份有限公司 关于合计持股 5%以上股东权益变动触及 1%刻度的公告 合计持股 5%以上股东苏州君联欣康创业投资合伙企业（有限合伙）和 HEALTH ADVANCE LIMITED 保证向本公司提供的信息内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 爱迪特（秦皇岛）科技股份有限公司（以下简称"公司"）于 2025 年 7 月 24 日在巨潮资讯网披露了《关于持股 5%以上股东减持股份预披露公告》（公告 编号：2025-027）（以下简称"本次减持计划"）。公司持股 5%以上股东苏州 君联欣康创业投资合伙企业（有限合伙）（以下简称"君联欣康"）以及康拓有 限公司（HEALTH ADVANCE LIMITED）（以下简称"HAL"）计划自上述公 告披露之日起 15 个交易日之后 3 个月内通过集中竞价或大宗交易方式减持公司 股份，减持数量合计不超过 3,196,930 股（占公司总股本的 3.0000%）。其中， 通过集中竞价方式 ...

Group 1 - The core viewpoint is that Aidi Te (爱迪特) has successfully expanded the sales of its Wolan implants across major provinces in China and has entered public hospitals in several provinces [1] - The company leverages collective procurement and channel advantages to establish partnerships with multiple national and regional chain dental institutions [1] - The products of Wolan are widely available in private dental clinics and specialized hospitals [1]

证券日报网讯爱迪特（301580）11月7日在互动平台回答投资者提问时表示，出于商业保密与供应链安 全考虑，暂无法披露公司具体供应商名单。 ...

证券代码： 301580 证券简称：爱迪特 公告编号： 2025-054 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 爱迪特（秦皇岛）科技股份有限公司（以下简称"公司"）于 2025 年 7 月 2 日召开第三届董事会第二十次会议审议通过了《关于变更注册资本、修订<公 司章程>的议案》，并于 2025 年 7 月 22 日召开 2025 年第一次临时股东会审议 通过了《关于变更注册资本、修订<公司章程>的议案》，具体内容详见公司刊 登在中国证监会指定创业板信息披露媒体巨潮资讯网（http://www.cninfo.com.cn） 的相关公告。 一、工商变更登记情况 注册资本：10,656.4537 万元人民币 爱迪特（秦皇岛）科技股份有限公司 关于公司完成工商变更登记并换发营业执照的公告 近期，公司已办理完成工商变更登记及《公司章程》备案手续，并取得了 由秦皇岛市市场监督管理局换发的《营业执照》，变更后的相关登记信息如下： 名称：爱迪特（秦皇岛）科技股份有限公司 统一社会信用代码：91130300799573001U 类型：股份有限公司（中外合资、上市） ...

证券代码：301580 证券简称：爱迪特 公告编号：2025-053 上述募集资金已于 2024 年 6 月全部到位，容诚会计师事务所（特殊普通合伙） 对上述募集资金到位情况进行了审验，并于 2024 年 6 月 21 日出具《验资报告》 （容诚验字〔2024〕215Z0015 号）。 二、募集资金存放和管理情况 为规范公司募集资金管理，保护投资者权益，根据《上市公司募集资金监管 规则》《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律 监管指引第 2 号——创业板上市公司规范运作》及公司《募集资金管理制度》等 有关规定，公司设立了募集资金专项账户，并与相关银行及保荐机构中信建投证 券股份有限公司分别签订了《募集资金三方监管协议》，对募集资金的存放和使 用 进 行 专 户 管 理 ， 具 体 内 容 详 见 公 司 于 2024 年 7 月 3 日 在 巨 潮 资 讯 网 （http://www.cninfo.com.cn）披露的《关于签订募集资金三方监管协议的公告》 （公告编号 2024-001）。 截至本公告披露日，公司募集资金专户情况如下： 1 爱迪特（秦皇岛）科技股份有限公司 关于注销部 ...

Core Insights - On November 5, a block trade of 125,000 shares of Aidi Te was executed, amounting to 5.595 million yuan, which represented 9.35% of the total trading volume for the day [1][2] - The transaction price was 44.76 yuan per share, reflecting a discount of 0.71% compared to the market closing price of 45.08 yuan [1][2] Summary by Category Trading Activity - The block trade involved 125,000 shares of Aidi Te, with a total transaction value of 5.595 million yuan [1][2] - The trade accounted for 9.35% of the total trading volume on that day [1] Pricing Details - The executed price for the shares was 44.76 yuan, which is lower than the market closing price of 45.08 yuan, indicating a discount of 0.71% [1][2]

Group 1: Company Performance and Outlook - The overall business growth trend is stable, with high revenue levels in Q2 and Q4 historically [3] - Management aims to maintain market insight and strategic focus to consolidate 2025 performance [3] - The gross margin slightly decreased due to policy changes affecting export tax rebates [3] Group 2: Customer Engagement and Product Validation - High customer loyalty and repurchase rates are noted, with core material validation taking 3 to 6 months [3] - The company’s digital equipment can effectively perform edentulous jaw scans, enhancing clinical efficiency [4] Group 3: Financial Metrics and Cost Management - The sales expense ratio decreased by 0.62 percentage points in Q3, attributed to normal fluctuations [5] - The company will continue to align investment with market share and profitability [5] Group 4: Future Development and Innovation - The new dental industry park will focus on CAD/CAM material industrialization and digital service platforms [6] - Plans to enhance production capacity and optimize product structure to cover a broader customer base [6] - The company will introduce new materials for various clinical needs, including edentulous treatment [7] Group 5: Market Strategy and Global Presence - Currently, the company’s consumables are not included in centralized procurement, with a controlled impact on performance if included [8] - The company has subsidiaries in key markets like the USA, Germany, and Japan, with over 60 local employees globally [9] - A direct sales team in the USA collaborates with over 200 dental processing companies, while Europe employs a "direct sales + distribution" model [9]

Group 1 - The core transaction involved 125,000 shares of Aidi Te, with a total transaction value of 5.6 million yuan, accounting for 7.44% of the total trading volume on that day [1][2] - The transaction price was 44.8 yuan per share, which represents a discount of 0.71% compared to the market closing price of 45.12 yuan [1][2] - The buyer was an institutional entity, while the seller was from China Zhongjin Wealth Securities [2]

Core Viewpoint - The company is responding to increasing order demand by enhancing production efficiency through automation and plans to significantly boost capacity with the construction of a new dental industry park by August 2025 [2]. Group 1 - The company is currently addressing the growing order demand by introducing automated equipment across various production process modules to improve efficiency [2]. - The construction of the dental industry park is set to officially commence in August 2025, which will notably increase the production capacity and operational efficiency of the company's core products [2].